标普和纳斯达克内在价值 联系我们

Kali, Inc. KALY OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
26/100
0/3 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Kali, Inc. (KALY) .

本页证实的标准:

  • VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分: 23/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score
26/100
SG Score
View full scorecard →
价值
N/A
No coverage
未來
N/A
No coverage
过去
0/100
→ Income
健康
50/100
Debt-to-Equity & liquidity
→ Health
护城河
28/100
→ Income
成长
N/A
No coverage
收入
N/A
No coverage

估值概览 — KALY

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$0.00
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%

EPS:实际 vs 预期

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2011 $5.36 $88.83M $13.48M 15.2%
2012 $6.78 $94.55M $17.52M 18.5%
2015 $0.00 $83.62K $-5.13K -6.1%
2016 $0.00 $71.54K $1.35K 1.9%
2017 $0.00 $67.59K $-9.31K -13.8%
2018 $0.00 $65.27K $-11.9K -18.2%
2019 $0.00 $0.00 $0.00 -
2020 $0.00 $0.00 $0.00 -
2021 $0.00 $0.00 $0.00 -
2022 $0.00 $0.00 $0.00 -
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言